Retinoic acid
Sponsors
M.D. Anderson Cancer Center, University of Iowa, University of North Carolina, Chapel Hill, Sun Yat-sen University, University of Cologne
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAutismCentral Centrifugal Cicatricial Alopecia (CCCA)Dup15Q SyndromeHER2 Negative Breast CancerHypercholesterolemiaMelasmaNeuroblastoma
Early Phase 1
Retinoic Acid Supplementation and Subjects With Hypercholesterolemia
CompletedNCT02497833
Start: 2014-11-30End: 2015-05-31Updated: 2015-07-15
DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.
CompletedNCT03392623
Start: 2015-01-01End: 2016-12-01Updated: 2018-01-09
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
CompletedNCT03491267
Start: 2018-01-01End: 2024-11-01Updated: 2025-07-03
A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome
NCT05281965
Start: 2022-04-01End: 2024-06-01Target: 20Updated: 2022-03-16
Phase 1
Phase 2
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
WithdrawnNCT01048086
Start: 2009-06-30End: 2013-11-30Updated: 2016-06-21
Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
WithdrawnNCT01275274
Start: 2012-01-31End: 2013-12-31Updated: 2017-02-23
NB2013-HR German (GPOH) / Dutch (DCOG) Trial
TerminatedNCT02641782
Start: 2015-11-30End: 2017-01-30Updated: 2022-11-04
Reverse HER2-negative Immune Resistant Breast Cancer
RecruitingNCT06731140
Start: 2025-02-12End: 2027-10-31Target: 10Updated: 2025-11-17